Upgrade to SI Premium - Free Trial

Kazia Therapeutics (KZIA)

11.40 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (9/9/25 *Est.)

Latest Headlines

Form 3 KAZIA THERAPEUTICS LTD For: Mar 18 Filed by: Davidson Ebru June 3, 2026 8:20 PM - SEC Filing The Multi-Billion-Dollar Search for Better Glioblastoma Treatments June 3, 2026 9:29 AM - StreetInsider Form 424B3 KAZIA THERAPEUTICS LTD June 2, 2026 9:05 AM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD June 2, 2026 9:03 AM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD June 2, 2026 9:02 AM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD June 2, 2026 9:01 AM - SEC Filing Form 6-K KAZIA THERAPEUTICS LTD For: Jun 02 June 2, 2026 9:00 AM - SEC Filing Kazia Therapeutics names James Levine as CFO June 2, 2026 7:30 AM - StreetInsider Kazia Therapeutics Appoints James Levine as Chief Financial Officer June 2, 2026 7:30 AM - PR NewsWire Form SCHEDULE 13G/A KAZIA THERAPEUTICS LTD Filed by: Chernett Jorey May 27, 2026 10:32 AM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD May 26, 2026 8:05 AM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD May 26, 2026 8:04 AM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD May 26, 2026 8:03 AM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD May 26, 2026 8:02 AM - SEC Filing Form 6-K KAZIA THERAPEUTICS LTD For: May 26 May 26, 2026 8:00 AM - SEC Filing Kazia Therapeutics expands breast cancer trial enrollment to 36 patients May 26, 2026 7:30 AM - StreetInsider Kazia Therapeutics Expands Ongoing Phase 1b Trial of Paxalisib in Advanced Breast Cancer May 26, 2026 7:30 AM - PR NewsWire Form 3 KAZIA THERAPEUTICS LTD For: Apr 13 Filed by: Rao Sudha May 19, 2026 1:07 PM - SEC Filing Form 6-K KAZIA THERAPEUTICS LTD For: Apr 27 April 27, 2026 8:31 AM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD April 15, 2026 8:34 AM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD April 15, 2026 8:33 AM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD April 15, 2026 8:33 AM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD April 15, 2026 8:31 AM - SEC Filing Form 6-K KAZIA THERAPEUTICS LTD For: Apr 15 April 15, 2026 8:30 AM - SEC Filing Kazia Therapeutics names Dr. Sudha Rao as chief scientific officer April 15, 2026 8:01 AM - StreetInsider Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform April 15, 2026 8:01 AM - PR NewsWire Laidlaw Starts Kazia Therapeutics (KZIA) at Buy April 15, 2026 2:24 AM - StreetInsider Form 424B3 KAZIA THERAPEUTICS LTD April 13, 2026 5:27 PM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD April 13, 2026 5:26 PM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD April 13, 2026 5:26 PM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD April 13, 2026 5:25 PM - SEC Filing Form 6-K KAZIA THERAPEUTICS LTD For: Apr 13 April 13, 2026 5:24 PM - SEC Filing Kazia Therapeutics licenses SETDB1 drug platform for $1.39 million April 13, 2026 5:07 PM - StreetInsider Kazia Therapeutics Expands Oncology Platform with First-in-Class SETDB1 Inhibitor Drug Development Platform April 13, 2026 5:06 PM - PR NewsWire Form 3/A KAZIA THERAPEUTICS LTD For: Mar 18 Filed by: Friend John E. II April 9, 2026 5:24 PM - SEC Filing Form 3 KAZIA THERAPEUTICS LTD For: Mar 18 Filed by: Cain David April 1, 2026 9:21 AM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD April 1, 2026 6:03 AM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD April 1, 2026 6:03 AM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD April 1, 2026 6:02 AM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD April 1, 2026 6:02 AM - SEC Filing Form 6-K KAZIA THERAPEUTICS LTD For: Mar 31 March 31, 2026 4:57 PM - SEC Filing Form SCHEDULE 13G/A KAZIA THERAPEUTICS LTD Filed by: Chernett Jorey March 31, 2026 2:36 PM - SEC Filing Form SCHEDULE 13G/A KAZIA THERAPEUTICS LTD Filed by: Alumni Capital LP March 30, 2026 8:30 PM - SEC Filing Form 6-K KAZIA THERAPEUTICS LTD For: Dec 31 March 30, 2026 6:09 AM - SEC Filing Form EFFECT KAZIA THERAPEUTICS LTD March 30, 2026 6:08 AM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD March 19, 2026 5:19 PM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD March 19, 2026 5:17 PM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD March 19, 2026 5:14 PM - SEC Filing Form 424B3 KAZIA THERAPEUTICS LTD March 19, 2026 5:12 PM - SEC Filing Form 6-K KAZIA THERAPEUTICS LTD For: Dec 31 March 19, 2026 5:10 PM - SEC Filing Form 3 KAZIA THERAPEUTICS LTD For: Mar 18 Filed by: Coffey Steven R. S. March 18, 2026 7:18 PM - SEC Filing Form 3 KAZIA THERAPEUTICS LTD For: Mar 18 Filed by: Friend John E. II March 18, 2026 6:36 PM - SEC Filing Form 3 KAZIA THERAPEUTICS LTD For: Mar 18 Filed by: Simpson Jeremy March 18, 2026 6:33 PM - SEC Filing Form 3 KAZIA THERAPEUTICS LTD For: Mar 18 Filed by: Bonacorda Jeffrey March 18, 2026 5:55 PM - SEC Filing Form 3 KAZIA THERAPEUTICS LTD For: Mar 18 Filed by: APPLE ROBERT F March 18, 2026 5:48 PM - SEC Filing Kazia Therapeutics files to offer up to $200 million of stock March 18, 2026 6:11 AM - StreetInsider Form F-3 KAZIA THERAPEUTICS LTD March 18, 2026 6:06 AM - SEC Filing Full Article List